
GC13812
Ibrutinib Racemate
Also listed as PCI-32765 (Ibrutinib)
PCI-32765 (Ibrutinib) is an irreversible selective inhibitor of Bruton s tyrosine kinase (BTK) that selectively targets its kinase domain and modulates BTK downstream signaling by reducing its phosphorylating capacity with IC50 of 0·5 nM in cell-free assays
ChemicalCAS936563-96-1MW440.5FormulaC25H24N6O2
- CAS number
- 936563-96-1
- Molecular weight
- 440.5
- Formula
- C25H24N6O2
- Solubility
- ≥ 22·025mg/mL in DMSO
- InChIKey
- XYFPWWZEPKGCCK-UHFFFAOYSA-N
- Catalogue number
- GC13812
- Brand
- GLPBIO
Computed properties PubChem CID 16126651 · XLogP 3.6 · TPSA 99.2 Ų · H-bond donors 1
- XLogP
- 3.6
- TPSA
- 99.2 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 33
SMILES C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
Computed descriptors from PubChem (CID 16126651), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il